AgileMD

What AgileMD does

AgileMD is a privately held healthcare technology company, founded in 2011 and headquartered in San Francisco, that sells a cloud-based clinical decision support (CDS) platform to U.S. hospital systems. The platform is composed of two integrated products: eCART, an FDA 510(k)-cleared (K233253) machine-learning early warning system that provides real-time risk stratification for all-cause in-hospital clinical deterioration, and Clinical Pathways, an EHR-embedded protocol management system covering adult, pediatric, and neonate topics across ambulatory, emergency, inpatient, ICU, and women's health settings. eCART was developed in partnership with the University of Chicago over more than a decade and is built on a proprietary gradient boosted model trained on nearly 3 million patient encounters from 28 hospitals across 6 health systems, with both retrospective validation (~1.8M encounters) and prospective validation (200,000+ encounters) across sepsis, COPD, CHF, and COVID populations.

The underlying technology is delivered as a SOC 2 Type II and HIPAA-compliant cloud service that integrates directly into existing EHR workflows (including Epic), with no on-site hardware required and deployment timelines of days to weeks. AgileMD supplements this with 4,800+ active clinical pathways and 88+ peer-reviewed medical journal publications that function as clinical evidence rather than marketing collateral. The company monetizes the platform through enterprise SaaS subscriptions sold via direct field sales to hospital systems, with quote-based, non-refundable fees structured as monthly or annual contracts; pricing is not publicly disclosed. Customers include 400+ hospitals such as Yale New Haven Health, Johns Hopkins Medicine, UCHealth, Vanderbilt Health, UChicago Medicine, and Children's Hospital Colorado, supported by a lean operating team of 11–50 employees.

AgileMD is backed by Y Combinator, Rock Health, and MATTER, and has received non-dilutive capital from a $2M Phase II NIH SBIR grant (NIBIB, Award R44EB030955) and BARDA support tied to eCART's clearance as a medical countermeasure. The QuantHC merger (October 2019) combined the company's AI capabilities with a clinical pathways content library, forming the current platform shape. Revenue, ARR, and ownership structure beyond founders and accelerator backers are not publicly disclosed.

Name

AgileMD

Legal name

AgileMD, Inc.

Website

https://agilemd.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

AgileMD sells a cloud-based clinical decision support platform to U.S. hospital systems, combining an FDA-cleared machine-learning early warning system (eCART) for clinical deterioration with an EHR-embedded clinical pathways library, serving 400+ hospitals and 150,000+ clinical users.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Sepsis, Deterioration & Rapid Response CDS (HLACAGAF)

akta.pro secondary industries

AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), AI Triage & Clinical Decision Support (CDS) Platforms (HLALAJAD)

Keywords

• Clinical decision support
• Early warning system
• Clinical pathways software
• EHR-integrated analytics
• Hospital predictive analytics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise Software Subscription: Subscription-based licensing model for healthcare organizations. Customer pays subscription fees for access to the AgileMD platform including eCART and Clinical Pathways modules. Fees are non-refundable and can be structured as monthly or annual payment plans.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

AgileMD sells a cloud-based clinical decision support (CDS) platform that embeds into hospital electronic health record (EHR) systems and combines an FDA-cleared AI early warning system (eCART) with a clinical pathways content and workflow engine. The platform delivers real-time patient deterioration risk stratification, standardized evidence-based order sets and documentation, and practice-pattern benchmarking for inpatient, ED, ICU, and ambulatory care.

Product overview

AgileMD offers a unified clinical decision support platform consisting of two integrated products: eCART (FDA-cleared AI-powered clinical deterioration early warning system) and Clinical Pathways (EHR-integrated protocol management and guidance platform). Both products are deeply integrated into hospital electronic health records and share a common cloud-based CDS engine, enabling care teams to access real-time risk assessments alongside standardized clinical guidance within their existing workflows.

Differentiator

Problem solved

Functional benefit

Brands

• eCART: FDA-cleared Clinical Deterioration Early Warning and Workflow system for predicting and prioritizing high-risk patients using AI combined with actionable, embedded decision support for all-cause clinical deterioration

Products and services

• eCART (Clinical Deterioration Early Warning & Workflow) FDA-cleared AI-powered clinical deterioration early warning and workflow system that delivers real-time, all-cause clinical deterioration risk stratification embedded in the EHR, with actionable decision support for nurses and providers to identify, prioritize, and escalate care for high-risk inpatients. Trained and tested on nearly 3 million patient encounters from 28 hospitals across 6 health systems; validated retrospectively and prospectively on sepsis, COPD, CHF, and COVID populations.
• Clinical Pathways Highly-integrated, EHR-embedded clinical guidance and order set management platform that enables healthcare organizations to create, manage, and deploy 4,800+ evidence-based pathways across adult, pediatric, and neonate care settings (ambulatory, ED, inpatient, ICU, women's health), streamlining order entry, clinical documentation, clinical calculators, and lab/vitals integration directly within clinician workflow.

Quantifiable outcome

• 13% relative reduction in overall mortality (1.2% absolute) at Yale New Haven Health with eCART implementation over one year
• +5 more outcomes

Named customers13 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• BARDA (Biomedical Advanced Research and Development Authority)coreStrategic or Co-development PartnerSupported AgileMD's FDA clearance process for eCART as a medical countermeasure. BARDA partnership indicates government recognition of clinical deterioration detection as a public health priority. eCART became the latest FDA-cleared medical countermeasure with BARDA support.
• University of ChicagocoreStrategic or Co-development PartnerOrigin of eCART technology development. Partnership spanning over a decade of research and clinical implementation. Dr. Dana Edelson, co-founder, is affiliated with University of Chicago. eCART developed and validated using patient data from University of Chicago hospitals. AgileMD originated from this academic partnership.
• U.S. Food and Drug Administration (FDA)coreStrategic or Co-development PartnerFDA reviewed and cleared eCART through 510(k) process (K233253). AgileMD worked with FDA to demonstrate both retrospective and prospective validation of the device, including data from nearly 1.8 million encounters for retrospective testing and over 200,000 encounters for prospective validation.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Viz.ai: Specialty AI clinical decision support (originally stroke, expanding to other acute care); competes for the same CMO/CMIO buyer pursuing FDA-cleared AI tools and similar hospital economics.

Direct peers

• Etiometry: AI-driven clinical decision support focused on ICU and pediatric patient deterioration; competes most directly with eCART for the same hospital buyer, use case (early warning), and FDA pathway.
• Hospital IQ: AI platform for hospital operations including length-of-stay management, quality, and early warning; targets the same buyer (CMIO, CQO) and overlapping problem space (deterioration, throughput, mortality) as AgileMD.
• Wolters Kluwer (UpToDate Decision Support / Clinical Pathways): Established leader in evidence-based clinical decision support and pathways adopted at large academic and community hospitals; competes with AgileMD's Clinical Pathways and at the point-of-care reference layer.
• EBSCO Health (DynaMed): Point-of-care clinical reference and decision-support content used across hospitals; overlaps with AgileMD's evidence-backed pathway and order-set positioning for ambulatory and inpatient settings.
• Excel Medical (now part of GE Healthcare): Long-standing direct competitor in AI clinical deterioration prediction (e.g., BedMaster Ex, sepsis early warning). Acquired by GE Healthcare, which now bundles a comparable deterioration suite for hospital systems.

Broad incumbents

• Epic Systems: Dominant inpatient EHR whose embedded deterioration index and AI roadmap directly determine AgileMD's integration surface; the single most consequential strategic counterparty given Epic's footprint across AgileMD's named customers.
• Premier Inc. Healthcare performance and quality-improvement company serving thousands of US hospitals with analytics, benchmarking, and operational improvement; competes adjacently for CQO/quality budgets and improvement-program dollars.
• GE Healthcare (Mural Virtual Care / Sepsis AI): Hospital AI suite spanning sepsis detection, virtual ICU, and acute-care decision support; broad incumbent with overlapping deterioration and care-pathway use cases versus AgileMD's eCART and Pathways.
• Philips Healthcare (IntelliVue Early Warning / analytics): Large medical-device incumbent offering vital-sign monitoring, early warning scores, and ICU analytics at scale; competes on the same clinical-deterioration use case through a broader bedside-monitoring portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/agilemd
• LinkedInlinkedin.com/company/agilemd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AgileMD